Skip to main content

Drägerwerk AG & Co. KGaA (DGWPF)

New York Stock Exchange Healthcare Medical - DevicesView data quality →
64.2Fair

ValueMarkers Composite Index

Top 93%#3,300 of 44,707
Undervalued

76% below intrinsic value ($376)

UndervaluedFair ValueOvervalued
Piotroski
7/9
Strong
Beneish
-2.60
Low Risk
Altman
2.76
Grey Zone
DCF Value
$376
Undervalued
ROIC
6.0%
Low
P/E
12.8
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Drägerwerk AG & Co. KGaA (DGWPF) — VMCI valuation read

Drägerwerk AG & Co. KGaA (DGWPF) carries a VMCI composite of 64/100, 14 points above the Healthcare sector median of 50. Among mid-cap names, that gap places DGWPF in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The DGWPF insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads DGWPF trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of -0.5x leaves covenant headroom, the line to track on Drägerwerk AG & Co. KGaA's next 10-Q.

DGWPF rose 0.4% over the trailing 7 days, with a -7.7% read on a 30-day basis.

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.

CEO: Stefan A. Drager15,444 employeesDEwww.draeger.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in DGWPF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.